Metastasis From Pancreatic Cancer Located at the Incision Line of a Mastectomy: A Case Report and Review of Literature

Por Boysen, Anders Kindberg, Haarh, Vera, Soendergaard, Gorm, Yilmaz, Mette Karen
Publicado em 2011

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

Por Kjersem, Janne B, Skovlund, Eva, Ikdahl, Tone, Guren, Tormod, Kersten, Christian, Dalsgaard, Astrid M, Yilmaz, Mette K, Fokstuen, Tone, Tveit, Kjell M, Kure, Elin H
Publicado em 2014

miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3(rd) Line Cetuximab and Irinotecan

Por Schou, Jakob V., Rossi, Simona, Jensen, Benny V., Nielsen, Dorte L., Pfeiffer, Per, Høgdall, Estrid, Yilmaz, Mette, Tejpar, Sabine, Delorenzi, Mauro, Kruhøffer, Mogens, Johansen, Julia S.
Publicado em 2014

The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized pha...

Por ’t Lam - Boer, Jorine, Mol, Linda, Verhoef, Cornelis, de Haan, Anton F J, Yilmaz, Mette, Punt, Cornelis J A, de Wilt, Johannes H W, Koopman, Miriam
Publicado em 2014

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study

Por Tarpgaard, Line S., Guren, Tormod K., Glimelius, Bengt, Christensen, Ib J., Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Ikdahl, Tone, Yilmaz, Mette, Johansen, Julia S., Tveit, Kjell Magne
Publicado em 2014

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

Por Palshof, Jesper Andreas, Høgdall, Estrid Vilma Solyom, Poulsen, Tim Svenstrup, Linnemann, Dorte, Jensen, Benny Vittrup, Pfeiffer, Per, Tarpgaard, Line Schmidt, Brünner, Nils, Stenvang, Jan, Yilmaz, Mette, Nielsen, Dorte Lisbet
Publicado no BMC Cancer (2017)

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Por Schultz, Nicolai A., Christensen, Ib J., Werner, Jens, Giese, Nathalia, Jensen, Benny V., Larsen, Ole, Bjerregaard, Jon K., Pfeiffer, Per, Calatayud, Dan, Nielsen, Svend E., Yilmaz, Mette K., Holländer, Niels H., Wøjdemann, Morten, Bojesen, Stig E., Nielsen, Kaspar R., Johansen, Julia S.
Publicado em 2013